Pardes Biosciences (NASDAQ: PRDS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Pardes Biosciences (NASDAQ: PRDS) through any online brokerage.
There are no as such competitors for Pardes Biosciences.
The latest price target for Pardes Biosciences (NASDAQ: PRDS) was reported by SVB Leerink on Tuesday, March 15, 2022. The analyst firm set a price target for 18.00 expecting PRDS to rise to within 12 months (a possible 476.92% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Pardes Biosciences (NASDAQ: PRDS) is $3.12 last updated August 10, 2022, 8:00 PM UTC.
There are no upcoming dividends for Pardes Biosciences.
Pardes Biosciences’s Q3 earnings are confirmed for Friday, November 4, 2022.
There is no upcoming split for Pardes Biosciences.
Pardes Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.